Clinical Trials Browser

Phase 1 × ceritinib × Tumor-Agnostic × Clear all

NCT02321501 2025-11-10

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

Phase 1 Active not recruiting

Neoplasm Metastasis